Abnormalities in the Metabolism of Fatty Acids and Triacylglycerols in the Liver of the Goto-Kakizaki Rat: A Model for Non-Obese Type 2 Diabetes

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Lipids

• Publication date

  2016-07-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11745-016-4171-8PMID 27372943
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes

  2014cited by this paper
• Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes

  2014cited by this paper
• Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease

  2013cited by this paper
• Fibrates reduce triacylglycerol content by upregulating adipose triglyceride lipase in the liver of rats.

  2013cited by this paper
• Glycerol-3-phosphate Acyltransferase (GPAT)-1, but Not GPAT4, Incorporates Newly Synthesized Fatty Acids into Triacylglycerol and Diminishes Fatty Acid Oxidation*

  2013cited by this paper
• Increased Lipid Synthesis and Decreased β-Oxidation in the Liver of SHR/NDmcr-cp (cp/cp) Rats, an Animal Model of Metabolic Syndrome

  2013cited by this paper
• Up-Regulation of Stearoyl-CoA Desaturase 1 Increases Liver MUFA Content in Obese Zucker but Not Goto-Kakizaki Rats

  2013influential reference
• Liver and diabetes. A vicious circle

  2013cited by this paper
• High insulin levels are required for FAT/CD36 plasma membrane translocation and enhanced fatty acid uptake in obese Zucker rat hepatocytes.

  2012cited by this paper
• The GK rat: a prototype for the study of non-overweight type 2 diabetes.

  2012cited by this paper
• Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?

  2012cited by this paper
• Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

  2011cited by this paper
• Molecular therapy for obesity and diabetes based on a long‐term increase in hepatic fatty‐acid oxidation

  2011cited by this paper
• Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling.

  2011influential reference
• Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease

  2011cited by this paper
• Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways[S]

  2010influential reference
• Peroxisome Proliferator-Activated Receptor Alpha Target Genes

  2010influential reference
• The Role of PPARα Activation in Liver and Muscle

  2010cited by this paper
• Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease

  2009cited by this paper
• Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.

  2009cited by this paper
• Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

  2009cited by this paper
• Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver

  2009cited by this paper
• Identification of a physiologically relevant endogenous ligand for PPARalpha in liver.

  2009cited by this paper
• Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

  2008cited by this paper
• A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.

  2008cited by this paper
• Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots

  2007cited by this paper
• Comprehensive Analysis of PPARα-Dependent Regulation of Hepatic Lipid Metabolism by Expression Profiling

  2007influential reference
• Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway.

  2006cited by this paper
• Lipin 1 is an inducible amplifier of the hepatic PGC-1α/PPARα regulatory pathway

  2006cited by this paper
• Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis Published, JLR Papers in Press, June 2, 2006.

  2006cited by this paper
• "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.

  2005cited by this paper
• Primacy of beta-cell dysfunction in the development of hyperglycemia: a study in the Japanese general population.

  2004cited by this paper
• Effects of antihyperlipidemic agents on hepatic insulin sensitivity in perfused Goto-Kakizaki rat liver

  2004cited by this paper
• Obesity and type 2 diabetes in Japanese patients.

  2003cited by this paper
• Triglyceride accumulation protects against fatty acid-induced lipotoxicity

  2003cited by this paper
• Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.

  2002cited by this paper
• Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration.

  2002cited by this paper
• Fatty acid import into mitochondria.

  2000cited by this paper
• Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.

  2000cited by this paper
• Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes.

  2000cited by this paper
• Fatty acid oxidation affects food intake by altering hepatic energy status.

  1999cited by this paper
• Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B.

  1999cited by this paper
• Increase in hepatic content of oleic acid induced by dehydroepiandrosterone in the rat.

  1999cited by this paper
• The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

  1997cited by this paper
• Impaired insulin secretion and excessive hepatic glucose production are both early events in the diabetic GK rat.

  1996cited by this paper
• Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver.

  1995cited by this paper
• Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver.

  1993cited by this paper
• Localization of the carbohydrate response element of the rat L-type pyruvate kinase gene.

  1991influential reference
• Study of some factors controlling fatty acid oxidation in liver mitochondria of obese Zucker rats.

  1986cited by this paper
• In vivo hepatic and peripheral insulin resistance in genetically obese (fa/fa) rats.

  1983cited by this paper
• Altered hepatic metabolism of free fatty acids underlying hypersecretion of very low density lipoproteins in the genetically obese Zucker rats.

  1982influential reference
• Oxidation and ketogenesis in hepatocytes of lean and obese Zucker rats.

  1982cited by this paper
• Effects of di-(2-ethylhexyl)phthalate administration on carbohydrate and fatty acid metabolism in rat liver.

  1978cited by this paper
• Spontaneous Diabetes Produced by Selective Breeding of Normal Wistar Rats

  1975cited by this paper
• Fatty-acid synthase from rat liver.

  1975cited by this paper
• Acetyl Coenzyme A

  1965cited by this paper
• A RAPID METHOD FOR CHOLESTEROL DETERMINATION WITH A SINGLE REAGENT.

  1964cited by this paper
• [The liver and diabetes].

  1962influential reference
• A rapid method of total lipid extraction and purification.

  1959cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Effect of ammonium fluoride as a mobile phase additive on quantitativity of fatty acids in electrospray ionization–liquid chromatography–tandem mass spectrometry

  2025cites this paper
• Bone marrow transplantation attenuates inflammation and improves glycemic control in type 2 non-obese diabetic Goto-Kakizaki rats.

  2025cites this paper
• Gastrectomy promoted diabetes remission involves the molecular clock and epigenetic mechanisms in a rat model of lean type 2 diabetes

  2025cites this paper
• Liver glycogen catabolism in young adult Goto-Kakizaki rats.

  2025cites this paper
• Development of the Quantification of Fatty Acid Species without Derivatization and Application to Their Profiling in Sera of Different Mammalian Species

  2025cites this paper
• Improved Glucose Homeostasis Following Vertical Sleeve Gastrectomy is Associated with Alternate Wiring of the Liver Molecular Clock in a Rat Model of Spontaneously-Occurring Type 2 Diabetes

  2023cites this paper
• The need for adjusting experimental models to meet clinical reality.

  2022cites this paper
• Peripheral metabolic effects of ozone exposure in healthy and diabetic rats on normal or high-cholesterol diet.

  2021cites this paper
• Diabetes-Induced Inflammation and Vascular Alterations in the Goto–Kakizaki Rat Retina

  2020cites this paper
• Effect of feeding type 2 diabetes mellitus rats with synbiotic yogurt sweetened with monk fruit extract on serum lipid levels and hepatic AMPK (5' adenosine monophosphate-activated protein kinase) signaling pathway.

  2020cites this paper
• Untargeted metabolomics analysis on Cicer arietinium L.-Induced Amelioration in T2D rats by UPLC-Q-TOF-MS/MS.

  2020cites this paper
• Changes of Resting Energy Expenditure in Type 2 Diabetes Rats After Roux-en-Y Gastric Bypass

  2020cites this paper
• Effects of Resveratrol in Goto-Kakizaki Rat, a Model of Type 2 Diabetes

  2019cites this paper
• Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes

  2018cites this paper
• Fecal Metabolomics of Type 2 Diabetic Rats and Treatment with Gardenia jasminoides Ellis Based on Mass Spectrometry Technique.

  2018cites this paper
• Increase in liver cytosolic lipases activities and VLDL-TAG secretion rate do not prevent the non-alcoholic fatty liver disease in cafeteria diet-fed rats.

  2018cites this paper
• Fecal metabolomics reveals the positive effect of ethanol extract of propolis on T2DM mice

  year unknowncites this paper